Literature DB >> 20040926

Glial dysfunction in abstinent methamphetamine abusers.

Napapon Sailasuta1, Osama Abulseoud, Kent C Harris, Brian D Ross.   

Abstract

Persistent neurochemical abnormalities in frontal brain structures are believed to result from methamphetamine use. We developed a localized (13)C magnetic resonance spectroscopy (MRS) assay on a conventional MR scanner, to quantify selectively glial metabolic flux rate in frontal brain of normal subjects and a cohort of recovering abstinent methamphetamine abusers. Steady-state bicarbonate concentrations were similar, between 11 and 15 mmol/L in mixed gray-white matter of frontal brain of normal volunteers and recovering methamphetamine-abusing subjects (P>0.1). However, glial (13)C-bicarbonate production rate from [1-(13)C]acetate, equating with glial tricarboxylic acid (TCA) cycle rate, was significantly reduced in frontal brain of abstinent methamphetamine-addicted women (methamphetamine 0.04 micromol/g per min (N=5) versus controls 0.11 micromol/g per min (N=5), P=0.001). This is equivalent to 36% of the normal glial TCA cycle rate. Severe reduction in glial TCA cycle rate that normally comprises 10% of total cerebral metabolic rate may impact operation of the neuronal glial glutamate cycle and result in accumulation of frontal brain glutamate, as observed in these recovering methamphetamine abusers. Although these are the first studies to define directly an abnormality in glial metabolism in human methamphetamine abuse, sequential studies using analogous (13)C MRS methods may determine 'cause and effect' between glial failure and neuronal injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040926      PMCID: PMC2949186          DOI: 10.1038/jcbfm.2009.261

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  45 in total

Review 1.  Magnetic resonance spectroscopic approaches to studying neuronal: glial interactions.

Authors:  Jun Shen; Douglas L Rothman
Journal:  Biol Psychiatry       Date:  2002-10-01       Impact factor: 13.382

2.  Alternative 1-(13)C glucose infusion protocols for clinical (13)C MRS examinations of the brain.

Authors:  A Moreno; S Blüml; J H Hwang; B D Ross
Journal:  Magn Reson Med       Date:  2001-07       Impact factor: 4.668

3.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

4.  Tricarboxylic acid cycle of glia in the in vivo human brain.

Authors:  S Blüml; A Moreno-Torres; F Shic; C-H Nguy; B D Ross
Journal:  NMR Biomed       Date:  2002-02       Impact factor: 4.044

5.  Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study.

Authors:  T Ernst; L Chang; M Leonido-Yee; O Speck
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

6.  Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism.

Authors:  Vincent Lebon; Kitt F Petersen; Gary W Cline; Jun Shen; Graeme F Mason; Sylvie Dufour; Kevin L Behar; Gerald I Shulman; Douglas L Rothman
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

7.  [1-13C]glucose MRS in chronic hepatic encephalopathy in man.

Authors:  S Blüml; A Moreno-Torres; B D Ross
Journal:  Magn Reson Med       Date:  2001-06       Impact factor: 4.668

8.  Measurement of the tricarboxylic acid cycle rate in human grey and white matter in vivo by 1H-[13C] magnetic resonance spectroscopy at 4.1T.

Authors:  G F Mason; J W Pan; W J Chu; B R Newcomer; Y Zhang; R Orr; H P Hetherington
Journal:  J Cereb Blood Flow Metab       Date:  1999-11       Impact factor: 6.200

9.  Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study.

Authors:  Yoshimoto Sekine; Yoshio Minabe; Masayoshi Kawai; Katsuaki Suzuki; Masaomi Iyo; Haruo Isoda; Harumi Sakahara; Charles R Ashby; Nori Takei; Norio Mori
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

10.  Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers.

Authors:  Yang-Tae Kim; Sang-Woo Lee; Do-Hoon Kwon; Ji-Hyoung Seo; Byeong-Cheol Ahn; Jaetae Lee
Journal:  J Psychiatr Res       Date:  2009-04-23       Impact factor: 4.791

View more
  22 in total

1.  Real-time molecular imaging of tricarboxylic acid cycle metabolism in vivo by hyperpolarized 1-(13)C diethyl succinate.

Authors:  Niki M Zacharias; Henry R Chan; Napapon Sailasuta; Brian D Ross; Pratip Bhattacharya
Journal:  J Am Chem Soc       Date:  2011-12-22       Impact factor: 15.419

Review 2.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

Review 3.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

Review 4.  13C MRS studies of neuroenergetics and neurotransmitter cycling in humans.

Authors:  Douglas L Rothman; Henk M De Feyter; Robin A de Graaf; Graeme F Mason; Kevin L Behar
Journal:  NMR Biomed       Date:  2011-08-31       Impact factor: 4.044

Review 5.  Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.

Authors:  Luke A Downey; Jennifer M Loftis
Journal:  Eur J Pharmacol       Date:  2014-01-28       Impact factor: 4.432

6.  Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamine.

Authors:  Kevin D Lominac; Arianne D Sacramento; Karen K Szumlinski; Tod E Kippin
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

7.  A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice.

Authors:  Carlos D Silva; Ana F Neves; Ana I Dias; Hugo J Freitas; Sheena M Mendes; Inês Pita; Sofia D Viana; Paulo A de Oliveira; Rodrigo A Cunha; Carlos A Fontes Ribeiro; Rui D Prediger; Frederico C Pereira
Journal:  Neurotox Res       Date:  2013-09-26       Impact factor: 3.911

8.  Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects.

Authors:  Napapon Sailasuta; Osama Abulseoud; Martha Hernandez; Poone Haghani; Brian D Ross
Journal:  Subst Abuse       Date:  2010-04-07

Review 9.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015

10.  Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit.

Authors:  Ashley North; Jarod Swant; Michael F Salvatore; Joyonna Gamble-George; Petra Prins; Brittany Butler; Mukul K Mittal; Rebecca Heltsley; John T Clark; Habibeh Khoshbouei
Journal:  Synapse       Date:  2013-02-08       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.